NCT03460860

Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating The Safety And Efficacy Of An Oral Supplement Containing Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: United Laboratories · Industry
• Sex: All
• Age: 30 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the clinical efficacy of a combination of Astaxanthin (2 mg), Lycopene (1.8 mg), and d-alpha-Tocopherol (10 IU) in terms of its skin anti-aging properties. Specifically, the investigators aim to determine the increase in hydration levels of the skin, decrease in atypical skin pigmentation, and reduction of signs of photoaging, particularly facial fine lines.

Conditions

• Skin Aging
• Wrinkles

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Astaxanthin (2mg)+Lycopene (1.8mg)+D-Alpha-Tocopherol (10IU)	The intervention is to be taken once daily, for 12 weeks.
DIETARY_SUPPLEMENT	Placebo	The intervention is to be taken once daily, for 12 weeks.

Timeline

• Start date: 2018-03-05
• Primary completion: 2018-10-10
• Completion: 2019-02-07
• First posted: 2018-03-09
• Last updated: 2019-06-26

Locations

1 site across 1 country: Philippines